BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16061895)

  • 1. Can we better prioritize resources for cost-utility research?
    Neumann PJ; Rosen AB; Greenberg D; Olchanski NV; Pande R; Chapman RH; Stone PW; Ondategui-Parra S; Nadai J; Siegel JE; Weinstein MC
    Med Decis Making; 2005; 25(4):429-36. PubMed ID: 16061895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing face of the cost-utility literature, 1990-2012.
    Neumann PJ; Thorat T; Shi J; Saret CJ; Cohen JT
    Value Health; 2015 Mar; 18(2):271-7. PubMed ID: 25773562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the burden of disease in the United States using disability-adjusted life years.
    McKenna MT; Michaud CM; Murray CJ; Marks JS
    Am J Prev Med; 2005 Jun; 28(5):415-23. PubMed ID: 15894144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life after stroke: review of the literature and implications for future research.
    Tseng MC; Lin HJ
    Acta Neurol Taiwan; 2007 Mar; 16(1):7-12. PubMed ID: 17486727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of disease and injury in Serbia.
    Jankovic S; Vlajinac H; Bjegovic V; Marinkovic J; Sipetic-Grujicic S; Markovic-Denic L; Kocev N; Santric-Milicevic M; Terzic-Supic Z; Maksimovic N; Laaser U
    Eur J Public Health; 2007 Feb; 17(1):80-5. PubMed ID: 16751634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost utility for penetrating keratoplasty in patients with poor binocular vision.
    Hirneiss C; Neubauer AS; Niedermeier A; Messmer EM; Ulbig M; Kampik A
    Ophthalmology; 2006 Dec; 113(12):2176-80. PubMed ID: 16996598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
    Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling costs and burden of informal caregiving for persons with bipolar disorder.
    Wolff N; Perlick DA; Kaczynski R; Calabrese J; Nierenberg A; Miklowitz DJ
    J Ment Health Policy Econ; 2006 Jun; 9(2):99-110. PubMed ID: 17007487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social aspects of HIV and their relationship to craniofacial problems: workshop 4C.
    Umadevi KR; Blignaut E; Glick M; Nasir E; Yengopal V; Younai F; Robinson PG
    Adv Dent Res; 2011 Apr; 23(1):117-21. PubMed ID: 21441492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.